99mTc-Octreotide uptake in the uterus and a subserosal myoma mimicking tumoral masses

4Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

The diagnostic usefulness of somatostatin receptor scintigraphy in the localization of tumors has been evaluated in several studies. Here, we present the case of a patient with a subserosal myoma diagnosed by 99mTc-labeled octreotide acetate scintigraphy. Oval and ring-shaped areas of hyperactivity in the pelvis were confirmed on MR imaging to be the uterus and a subserosal myoma. The presented case indicates that somatostatin receptors may be present in the uterus and in leiomyomas, especially in young women, and demonstrates that somatostatin may be a promising therapy for treatment of myoma. The case also demonstrates that subserosal myoma or dislocation of the uterus can result in a false-positive diagnosis, highlighting the importance of correlative imaging for accurate interpretation of the study. © 2014 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Cite

CITATION STYLE

APA

Pirayesh, E., Amoui, M., & Assadi, M. (2014). 99mTc-Octreotide uptake in the uterus and a subserosal myoma mimicking tumoral masses. Journal of Nuclear Medicine Technology, 42(1), 77–78. https://doi.org/10.2967/jnmt.113.131581

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free